Application 216976
- Type
- ANDA
- Sponsor
- MYLAN PHARMACEUTICALS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | APREPITANT | APREPITANT | INJECTION, EMULSION | 130MG/18ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| APREPITANT | APREPITANT | Torrent Pharmaceuticals Limited | af9b6086-4bf2-472c-8740-4134eaaebace | 2026-06-11 | Warnings, Adverse reactions | APREPITANT APREPITANT |
| CINVANTI | APREPITANT | Heron Therapeutics, Inc. | 4c218d3a-a508-4abc-9ed8-a6e8e191d1b4 | 2026-04-01 | Warnings, Adverse reactions | APREPITANT |
| APONVIE | APREPITANT | Heron Therapeutics, Inc. | d1b111eb-659a-496b-a86a-8f0fa370f147 | 2026-04-01 | Warnings, Adverse reactions | APREPITANT |
| Aprepitant | APREPITANT | BluePoint Laboratories | a78aaa00-a46b-4f9e-a415-2fca9e9a4fb4 | 2026-03-27 | Warnings, Adverse reactions | Aprepitant APREPITANT |
| APREPITANT | APREPITANT | Golden State Medical Supply, Inc. | 377c3ecb-fdec-dde4-e063-6294a90a29bd | 2026-03-09 | Warnings, Adverse reactions | APREPITANT APREPITANT |
| Aprepitant | APREPITANT | Glenmark Pharmaceuticals Inc., USA | d72e0e10-4557-41b0-b65d-d395468cad19 | 2026-01-28 | Warnings, Adverse reactions | Aprepitant APREPITANT |
| Aprepitant | APREPITANT | Sandoz Inc | f58b8944-93ee-4be1-a238-cc0061ddd93a | 2024-09-09 | Warnings, Adverse reactions | Aprepitant APREPITANT |
| EMEND | APREPITANT | Merck Sharp & Dohme LLC | 696f9e80-9cae-403b-de9e-078343ce4713 | 2024-07-05 | Warnings, Adverse reactions | APREPITANT |